Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

A Multicentre, Open Label, Observational, Non-interventional Study to Evaluate the Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes Mellitus

The study is conducted in Europe. The aim of this observational study is to assess glycaemic control while using liraglutide under normal clinical practice conditions in Belgium.

Inclusion Criteria:

• Type 2 diabetes
• Insufficiently controlled after 3 months of treatment with OADs (oral anti-diabetic drugs)

Exclusion Criteria:

• Previously treated with liraglutide
• Hypersensitivity to liraglutide or to any of the excipients (Disodium phosphate dihydrate, propylene glycol, phenol, water for injections)
• Pregnant, breast feeding or have the intention of becoming pregnant